Implication for health policy/practice/research/medical education:
Metformin, a commonly consumed anti-diabetic medication, has an ameliorative impact on some cancers by direct (preventing
cell growth and apoptosis) and indirect (increasing insulin sensitivity) effects.
Please cite this paper as: Dorestan N, Bahadoram M, Khosravi M, Bahadoram S, Davoodi M, Barahman M. Beyond
renoprotective impact; ameliorative effects of metformin on malignancies. J Nephropharmacol. 2017;7(2):50-54.